Group 1 - The core point of the news is the performance of Chutian Convertible Bonds, which experienced a decline of 2.1% to 131.369 yuan per share, with a trading volume of 30.03 million yuan and a conversion premium rate of 18.79% [1] - Chutian Convertible Bonds have a credit rating of "AA" and a maturity period of 6 years, with interest rates increasing from 0.30% in the first year to 2.00% in the sixth year [1] - The conversion price for the bonds is set at 8.0 yuan, with the conversion start date on August 6, 2024 [1] Group 2 - Chutian Technology Co., Ltd. is a leading enterprise in the Chinese medical equipment industry, established in 2000, and is also recognized globally [2] - The company specializes in medical equipment and comprehensive technical solutions, and is a pioneer in the research and development of smart pharmaceutical factories [2] - For the first quarter of 2025, Chutian Technology reported a revenue of 1.0832 billion yuan, a year-on-year decline of 22.19%, and a net profit attributable to shareholders of -8.5569 million yuan, which is an increase of 59.0% year-on-year [2] - As of March 2025, the concentration of shares among the top ten shareholders is 47.22%, with a total of 26,860 shareholders and an average holding amount of 153,400 yuan per person [2]
楚天转债盘中下跌2.1%报131.369元/张,成交额3003.04万元,转股溢价率18.79%
Jin Rong Jie·2025-08-27 06:22